Lamotrigine Tablet, Orally Disintegrating
Product Images NDC 50228-321

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 50228-321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamotrigine-diagram.jpg (Lamotrigine Fig3)

Lamotrigine orally disintegrating tablets shown in four strengths: 25 mg, 50 mg, 100 mg, and 200 mg. Each strength is presented as white to off-white, round, flat-faced tablets with debossed codes SG 319, SG 320, SG 321, and SG 322 respectively on one side; the other side is plain.*

FDA Label Image

Lamotrigine (Lamotrigine Figure 2)

A line graph depicting failure probability (%) over weeks, comparing Lamotrigine and placebo treatments. The graph shows two survival curves labeled "LAMOTRIGINE" and "Placebo," with failure probability increasing over approximately 80 weeks. Censored data points are marked on each curve.*

FDA Label Image

Lamotrigine (Lamotrigine Figure1)

A Kaplan-Meier curve chart showing failure probability (%) over weeks for Lamotrigine versus placebo. The x-axis represents weeks up to 100, and the y-axis shows failure probability from 0 to 100%. The chart illustrates two curves labeled Lamotrigine and Placebo, with censored data points marked. Lamotrigine shows a consistently lower failure probability compared to placebo over time.*

FDA Label Image

25 (Lamotrigine Label1)

Lamotrigine 25 mg orally disintegrating tablets label from ScieGen Pharmaceuticals, Inc. The label includes the product name, strength, dosage form, and a pink tablet image scored with "SG." It contains 30 tablets and includes storage instructions, a barcode, and a caution to verify dispensation.*

FDA Label Image

50 (Lamotrigine Label2)

Lamotrigine Orally Disintegrating Tablets 50 mg packaging label by ScieGen Pharmaceuticals, Inc. The label indicates that each tablet contains 50 mg of lamotrigine. It includes dosage instructions, storage recommendations, and a warning to keep medication out of reach of children. The package contains 30 tablets and is marked Rx only. The label also features the NDC code 50228-320-30 and manufacturer information in Hauppauge, NY.*

FDA Label Image

100 (Lamotrigine Label3)

Lamotrigine 100 mg orally disintegrating tablets label from ScieGen Pharmaceuticals, Inc. The label indicates 30 tablets per container, with storage instructions and safety warnings. The product is prescription only and includes directions to read accompanying prescribing information and for pharmacist dispensing.*

FDA Label Image

200 (Lamotrigine Label4)

Label for Lamotrigine Orally Disintegrating Tablets, 200 mg, manufactured by ScieGen Pharmaceuticals, Inc. The label includes dosage form and strength, NDC number 50228-322-30, caution and pharmacist dispensing instructions, storage conditions, and packaging details. The package contains 30 tablets.*

FDA Label Image

Structure (Lamotrigine Structure)

Chemical structure of lamotrigine, the active ingredient in the product Lamotrigine. The diagram shows its molecular arrangement with distinctive rings and substituents, including chlorine and amino groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.